Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDZenas BioPharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$1.12 | -$1.12 | -$1.12 |
| Q2 2025 | 1 | -$1.10 | -$1.10 | -$1.10 |
| Q3 2025 | 1 | -$0.97 | -$0.97 | -$0.97 |
| Q4 2025 | 1 | -$0.98 | -$0.98 | -$0.98 |
| Q1 2026 | 1 | -$1.05 | -$1.05 | -$1.05 |
| Q2 2026 | 1 | -$1.11 | -$1.11 | -$1.11 |
| Q3 2026 | 1 | -$1.14 | -$1.14 | -$1.14 |
| Q4 2026 | 1 | -$1.01 | -$1.01 | -$1.01 |
Zenas BioPharma, Inc. Earnings Date And Information
Zenas BioPharma, Inc. last posted its earnings results on Tuesday, March 11th, 2025. The company reported $-0.98 earnings per share for the quarter, missing analysts' consensus estimates of $-0.98 by $0. The company had revenue of 0 for the quarter and had revenue of 5.00 M for the year. Zenas BioPharma, Inc. has generated $-1 earnings per share over the last year ($-1.18 diluted earnings per share) and currently has a price-to-earnings ratio of -2.83. Zenas BioPharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Zenas BioPharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$9.33 | -$0.92 | 8.41 | $0 | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$0.99 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$0.73 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | N/A | -$0.64 | N/A | N/A | $0 |
| 09/30/2023 | Q3 2023 | N/A | $0.85 | N/A | N/A | $50.00 M |
| 06/30/2023 | Q2 2023 | N/A | -$0.76 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | N/A | -$0.50 | N/A | N/A | $0 |
| 12/31/2022 | Q4 2022 | N/A | $0.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Zenas BioPharma, Inc. Earnings: FAQ's
Zenas BioPharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based offlast year's report dates.
The conference call for Zenas BioPharma, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Zenas BioPharma, Inc.'s latest earnings report can be read online.
Zenas BioPharma, Inc. (:ZBIO) has a recorded annual revenue of $5.00 M.
Zenas BioPharma, Inc. (:ZBIO) has a recorded net income of $-156,130,000.Zenas BioPharma, Inc. has generated $-1.18 earnings per share over the last four quarters.
Zenas BioPharma, Inc. (:ZBIO) has a price-to-earnings ratio of -2.83 and price/earnings-to-growth ratio is 0.02.